Wissenschaftliche Arbeiten

Uzm. Dr. Mustafa Halil Akbörü

29 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. Kanserden Korunma Yolları

    Akademisyen Kitabevi eBooks, 2026

    DOI 10.37609/akya.4045.c4295 Quelle: ORCID

  2. Onkolojide Sık Kullanılan Kavramlar

    Akademisyen Kitabevi eBooks, 2026

    DOI 10.37609/akya.4045.c4301 Quelle: ORCID

  3. Kısa Radyoterapi Rehberi

    Akademisyen Kitabevi eBooks, 2026

    DOI 10.37609/akya.4096 Frei zugänglicher VolltextQuelle: ORCID

  4. Stereotactic radiosurgery for HER2-positive breast cancer brain metastases: prognostic factors and the evolving role of anti-HER2 therapies

    Breast Cancer, 2025

    DOI 10.1007/s12282-025-01731-5 PMID 40483635 1 Zitation (OpenAlex) Quelle: OpenAlex

  5. Evaluating the Impact of Age and G8 Assessment on Definitive Treatment Strategies in Elderly Patients with Local Advanced Esophageal Carcinoma

    Oncology Research and Treatment, 2024

    DOI 10.1159/000542017 PMID 39413748 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  6. Comprehensive analysis of stereotactic Radiosurgery outcomes in triple-negative breast cancer patients with brain metastases: The influence of immunotherapy and prognostic factors

    The Breast, 2024

    DOI 10.1016/j.breast.2024.103757 PMID 38843710 10 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  7. The crucial role of high C -reactive protein interval and Glasgow prognostic score for predicting prognosis in esophageal cancer patients undergoing chemoradiotherapy

    International Journal of Radiation Research, 2023

    DOI 10.61186/ijrr.21.3.485 Frei zugänglicher VolltextQuelle: ORCID

  8. A new perspective on the future of Turkish Society for Radiation Oncology: Young Radiation Oncologists Group (TROD/GROG 001)

    Reports of Practical Oncology & Radiotherapy, 2023

    DOI 10.5603/rpor.a2023.0004 PMID 37122905 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  9. Evaluation of Nutritional Status and Anxiety Levels in Patients Applying to the Radiation Oncology Outpatient Clinic during the COVID-19 Pandemic: Turkish Society for Radiation Oncology Group Study (TROD 12:02)

    Nutrition and Cancer, 2022

    DOI 10.1080/01635581.2022.2093386 PMID 35792709 Frei zugänglicher VolltextQuelle: ORCID

  10. Meme Kanserinde Hipofraksiyone Radyoterapi

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1888.c17269 Quelle: OpenAlex

  11. Meme Kanserinde İntraoperatif Radyoterapi

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1888.c17278 Quelle: OpenAlex

  12. The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy

    Journal of Gastrointestinal Cancer, 2021

    DOI 10.1007/s12029-021-00608-y PMID 33651265 11 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  13. The efficacy and tolerability of ultra-hypofractionated radiotherapy in low-intermediate risk prostate cancer patients: single center experience

    The Aging Male, 2021

    DOI 10.1080/13685538.2021.1948992 PMID 34233569 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  14. Fiducial Marker Practice in Prostate Radiotherapy in Turkey

    The Bulletin of Urooncology, 2021

    DOI 10.4274/uob.galenos.2021.1958 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  15. The Results of Adjuvant and Salvage Radiotherapy Following Radical Prostatectomy

    Bagcilar Medical Bulletin, 2021

    DOI 10.4274/bmb.galenos.2021.11.078.1 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  16. The impact of tumor regression grade on long-term survival in locally advanced rectal cancer treated with preoperative chemoradiotherapy

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155219900944 PMID 32046577 7 Zitationen (Europe PMC) Quelle: OpenAlex

  17. Changes in radiotherapy practice during COVID-19 outbreak in Turkey: A report from the Turkish Society for Radiation Oncology

    Radiotherapy and Oncology, 2020

    DOI 10.1016/j.radonc.2020.06.014 PMID 32544607 15 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  18. MON-PO380: Screening for Nutritional Status in Radiation Oncology Outpatients

    Clinical Nutrition, 2019

    DOI 10.1016/s0261-5614(19)32214-9 Quelle: OpenAlex

  19. Use of Intraoperative Radiotherapy in Pancreatic Cancer After Neoadjuvant Chemoradiotherapy: First National Application

    Bezmialem Science, 2016

    DOI 10.14235/bs.2016.821 Frei zugänglicher VolltextQuelle: ORCID

  20. Pankreas Kanserinde Neoadjuvan KemoradyoterapiSonrası İntraoperatif Radyoterapi Uygulaması: İlkUlusal Uygulama

    2016

    Quelle: OpenAlex

  21. Intraoperative Radiotherapy

    The Medical Journal of Okmeydani Training and Research Hospital, 2014

    DOI 10.5222/otd.supp1.2013.025 3 Zitationen (OpenAlex) Quelle: OpenAlex

  22. Radiotherapy for stage I seminoma of the testis

    Indian Journal of Cancer, 2010

    DOI 10.4103/0019-509x.63017 PMID 20448383 2 Zitationen (OpenAlex) Quelle: OpenAlex

  23. Raltitrexed concomitant with radiotherapy as neoadjuvant treatment in patients with locally advanced rectal carcinoma: A phase II study

    Turk Onkoloji Dergisi, 2009

    Quelle: ORCID

  24. A retrospective comparison of concurrent 5-fluoro-uracil or oral UFT in postoperative chemoradiation for gastric adenocarsinoma

    Cancer/Radiothérapie, 2009

    DOI 10.1016/j.canrad.2009.09.004 PMID 19963423 1 Zitation (OpenAlex) Quelle: OpenAlex

  25. 6626 Evaluation of our gastrointestinal stromal tumour cases and their response to treatment

    European Journal of Cancer Supplements, 2009

    DOI 10.1016/s1359-6349(09)71347-3 Quelle: OpenAlex

  26. Analysis of patients diagnosed as rectal carcinoma treated with neoadjuvant chemoradiotherapy and radiotherapy alone

    Journal of Clinical Oncology, 2007

    DOI 10.1200/jco.2007.25.18_suppl.14582 Quelle: OpenAlex

  27. Concomitant chemoradiotherapy with orally used agents in locally advanced gastric carcinoma: Two years results

    Journal of Clinical Oncology, 2006

    DOI 10.1200/jco.2006.24.18_suppl.14127 1 Zitation (OpenAlex) Quelle: OpenAlex

  28. An analysis and epidemiologic study on new cancer patients admitted to our department between 1999–2003

    Journal of Clinical Oncology, 2006

    DOI 10.1200/jco.2006.24.18_suppl.20108 Quelle: OpenAlex

  29. Neoadjuvant paclitaxel, carboplatin and concurrent weekly paclitaxel and conventional radiotherapy for locally advanced NSCLC

    Journal of Clinical Oncology, 2004

    DOI 10.1200/jco.2004.22.14_suppl.7361 1 Zitation (OpenAlex) Quelle: OpenAlex